[1]
|
Sterne, J.A., Hernan, M.A., Ledergerber, B., Tilling, K., Weber, R., Sendi, P., et al. (2005) Long-Term Effectiveness of Potent Antiretroviral Therapy in Preventing AIDS and Death: A Prospective Cohort Study. Lancet, 366, 378-384. http://dx.doi.org/10.1016/S0140-6736(05)67022-5
|
[2]
|
Hadigan, C., Meigs, J.B., Corcoran, C., Rietschel, P., Piecuch, S., Basgoz, N., et al. (2001) Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy. Clinical Infectious Diseases, 32, 130-139. http://dx.doi.org/10.1086/317541
|
[3]
|
Carr, A., Samaras, K., Burton, S., Law, M., Freund, J., Chisholm, D.J. and Cooper, D.A. (1998) A Syndrome of Peripheral Lipodystrophy, Hyperlipidaemia and Insulin Resistance in Patients Receiving HIV Protease Inhibitors. AIDS, 12, 51-58. http://dx.doi.org/10.1097/00002030-199807000-00003
|
[4]
|
Grundy, S.M., Brewer, H.B., Cleeman, J.I., Smith, S.C. and Lenfant, C. (2004) The American Heart Association, the National Heart, Lung and Blood Institute: Definition of Metabolic Syndrome: Report of the National Heart Association Conference on Scientific Issues Related to Definition. Circulation, 109, 433-438. http://dx.doi.org/10.1161/01.CIR.0000111245.75752.C6
|
[5]
|
Lakka, H.M., Laaksonen, D., Laaka, T.A., Niskanen, L.K., Kumpusalo, E., Tuomilehto, J., et al. (2002) The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-Aged Men. JAMA, 288, 2709-2716. http://dx.doi.org/10.1001/jama.288.21.2709
|
[6]
|
Reaven, G.M. (2006) The Metabolic Syndrome: Is This Diagnosis Necessary? The American Journal of Clinical Nutrition, 83, 1237-1247.
|
[7]
|
Saves, M., Chêne, G., Ducimetiere, P., Leport, C., Le Moal, G. and Amouyel, P. (2003) Risk Factor for Coronary Heart Diseases in Patients Treated for HIV-Infection Compared with the General Population. Clinical Infectious Diseases, 37, 292-298. http://dx.doi.org/10.1086/375844
|
[8]
|
Mondy, K., Overton, E., Grubb, J., Tong, S., Seyfried, W., Powerderly, W. and Yarasheski, K. (2007) Metabolic Syndrome in HIV-Infected Patients from an Urban, Midwestern US OUTPATIENT Population. Clinical Infectious Diseases, 44, 726-734. http://dx.doi.org/10.1086/511679
|
[9]
|
Jerico, C., Knobel, H., Montero, M., Knobel, H., Ordonez-Llanos, J., Guelar, A, et al. (2005) Metabolic Syndrome among HIV-Infected Patients: Prevalence, Characteristics, and Related Factors. Diabetes Care, 28, 144-149. http://dx.doi.org/10.2337/diacare.28.1.132
|
[10]
|
Sales, S., Campa, A., Makhema, J., Dusara, P., Tsalaile, L., Burns, P.J., et al. (2009) Metabolic Syndrome in HIV + Asymptomatic Adults in Botswana, Africa. The Journal of the Federation of American Societies for Experimental Biology, 918, 4.
|
[11]
|
Mhlabi, D.B. (2011) Metabolic Syndrome among People with Human Immunodeficiency Virus on Anti-retroviral Therapy at Princess Marina Hospital in Gaborone-Botswana.
|
[12]
|
Trinder, P. (1969) Determination of Blood Glucose Using an Oxydase-Peroxydase System with a Non Carcinogenic Chromogen. Journal of Clinical Pathology, 22, 158-161. http://dx.doi.org/10.1136/jcp.22.2.158
|
[13]
|
Roeschlau, P., Bernt, E. and Gruber, W.A. (1974) Enzymatic Analysis of Total Cholesterol. Clinical Biochemistry, 12, 226.
|
[14]
|
Buccolo, G. and David, H. (1973) Quantitative Determination of Serum Triglycerides by the Use of Enzymes. Clinical Chemistry, 19, 476-482.
|
[15]
|
Friedwald, W.T., Levy, R.I. and Fredrickson, D.S. (1972) Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, without Use of Preparative Ultracentrifuge. Clinical Chemistry, 18, 499-502.
|
[16]
|
NCEP-ATP III (2001) Executive Summary of the Third Report of The National Cholesterol Education Program in Adults (Adult Treatment Panel III). Journal of the American Medical Association, 285, 2486-2497. http://dx.doi.org/10.1001/jama.285.19.2486
|
[17]
|
The International Diabetes Federation (2005) The IDF Consensus Worldwide Definition of Metabolic Syndrome.
|
[18]
|
Worm, S.W., Friis-Moller, N., Bruyand, M., D’Arminio Monforte, A., Rickenbach, M., Reiss, P., et al. (2010) High Prevalence of the Metabolic Syndrome in HIV-Infected Patients: Impact of Different Definitions of the Metabolic Syndrome. AIDS, 24, 427-435. http://dx.doi.org/10.1097/QAD.0b013e328334344e
|
[19]
|
Enyegue, D.M., Ngondi, J.L., Fomekong, G.I., Agbor, G. and Oben, J.E. (2008) Prediction and Prevalence of Metabolic Syndrome in Overweight and Obese Subject in Cameroon’. International Journal of Biomedical and Pharmaceutical Sciences, 2, 117-121.
|
[20]
|
EDSC III (2004) Institut National de la Statistique, Troisième Enquête Démographique Santé, Loi n° 96, 12 du 5 Aoû t 1996 portant Loi-c, 250 p.
|
[21]
|
Ford, E.S., Gilles, W.H. and Dietz, W.H. (2002) Prevalence of the Metabolic Syndrome among US Adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA, 287, 356-359. http://dx.doi.org/10.1001/jama.287.3.356
|
[22]
|
Villamar, M.F., Albuja, A.C. and Salas, N.I. (2011) Metabolic Syndrome among HIV-Infected Outpatients from a Hospital in Quito, Ecuador: A Cross Sectionnal Study. Revista Panamericana Infectologia, 13, 12-18.
|
[23]
|
Alencastro, P.R., Wolff, F.H., Oliveira, R.R., Ikeda, M.L., Barcellos, N.T., Brandão, A.B. and Fuchs, S.C. (2012) Metabolic Syndrome and Population Attributable Risk among HIV) AIDS Patients: Comparison between NCEPATPIII, IDF and AHA) NHLBI Definitions. AIDS Research and Therapy, 9, 29. http://dx.doi.org/10.1186/1742-6405-9-29
|
[24]
|
Garcia-Garcia, E., De la Liata-Romero, M., Kaufer-Horwitz, M., Tusié-Luna, M.T., Calzada-Leon, R., VasquezVelazquez, V., et al. (2008) La Obesidad Y el Sindrome Metabolico como Problema de Salud Publica. Una Reflexion. Salud Pública de México, 50, 530-547. http://dx.doi.org/10.1590/S0036-36342008000600015
|
[25]
|
Grunfeld, C., Pang, M., Doerrler, W., Shigenaga, J.K., Jensen, P. and Feingold, K.R. (1992) Lipids, Lipoproteins, Triglyceride Clearance, and Cytokines in Human Immunodeficiency Virus Infection and the Acquired Immunodeficiency Syndrome. The Journal of Clinical Endocrinology and Metabolism, 74, 1045-1052.
|
[26]
|
Jacobson, D.L., Knox, T., Spiegelman, D., Skinner, S., Gorbach, S.L. and Wanke, C. (2005). Prevalence and Evolution of Fat Atrophy and Fat Deposition in a Cohort of HIV-Infected Men and Women. Clinical Infectious Diseases, 40, 1837-1845. http://dx.doi.org/10.1086/430379
|
[27]
|
Grinspoon, S. and Carr, A. (2005) Cardiovascular Risk and Body Fat Abnormalities in HIV-Infected Adults. The New England Journal of Medicine, 352, 48-62. http://dx.doi.org/10.1056/NEJMra041811
|
[28]
|
Riddler, S.A., Li, X., Chu, H., Kingsley, S.A., Dobs, A. and Evans, R. (2007) Longitudinal Changes in Serum Lipids among HIV-Infected Men on Highly Active Antiretroviral Therapy. HIV Medicine, 8, 280-287. http://dx.doi.org/10.1111/j.1468-1293.2007.00470.x
|
[29]
|
Samaras, K. (2007) Metabolic Consequences and Therapeutic Options in Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus-1 Infection. Journal of Antimicrobial Therapy Chemotherapy, 10, 1093-1100.
|